1) Betahistine
倍他司汀
1.
Clinical Study on Treatment of Vertebro-basilar Ischemic by Combined Injection of Betahistine and Shuxuetong;
疏血通倍他司汀治疗椎-基底动脉缺血性眩晕
2.
Clinical Study on Treatment of Vertebro-basilar Ischemic by Combined Injection of Betahistine and PGE1;
凯时(PGE1)联合倍他司汀治疗椎-基底动脉缺血性眩晕35例疗效观察
3.
Hemodynamic Study of Betahistine on Vertebrobasilar Artery Insufficiency;
倍他司汀治疗椎基底动脉供血不足血流动力学的研究
2) Betahistine Hydrochloride
盐酸倍他司汀
1.
Determination of Betahistine Hydrochloride and Soudium Chloride Injection by HPLC;
HPLC法测定盐酸倍他司汀氯化钠注射液的含量
2.
Determination of betahistine hydrochloride and the related substances of betahistine hydrochloride injection by HPLC;
离子对-HPLC法测定盐酸倍他司汀注射液中药物与有关物质含量
3.
Determination of the related substances in Betahistine Hydrochloride Sodium Chloride Injection by HPLC;
HPLC法测定盐酸倍他司汀氯化钠注射液的有关物质
3) Betahistine Hydrochloride Tablets
盐酸倍他司汀片
1.
Determination of Betahistine Hydrochloride Tablets by HPLC;
HPLC法测定盐酸倍他司汀片的含量
2.
The related substance of Betahistine Hydrochloride Tablets was determined at 261 nm by HPLC.
0mL/min,检测波长为261nm,用高效液相色谱法测定盐酸倍他司汀片的有关物质。
4) Betahistine mesylate
甲磺酸倍他司汀
1.
OBJECTIVE: To study the bioequivalence of domestic and imported betahistine mesylate in 20 healthy volunteers.
目的:对健康受试者单剂量口服国产和进口甲磺酸倍他司汀片后的药代动力学特性及生物等效性进行评价。
5) betahistine mesylate tablet
甲磺酸倍他司汀片
1.
Relative bioavailability of betahistine mesylate tablet in healthy volunteers;
甲磺酸倍他司汀片在健康人体的相对生物利用度
6) Ulinastatin
乌司他汀
1.
Experimental Study of Ulinastatin Protecting the Liver from Ischemia-reperfusion Injury in Rats;
乌司他汀对大鼠肝脏缺血再灌注损伤的保护作用
2.
The effect of ulinastatin on plasma endotoxin level in patients with severe acute pancreatitis and evaluation of therapeutic efficiency;
乌司他汀对重症急性胰腺炎血浆内毒素水平的影响及其疗效观察
3.
Method:Sixty patients with valve disease who receive valve replacement for the first time were divided into three groups: Ulinastatin group(group A), Ulinastatin and Aprotinin group (group B) and control group (group C).
方法:60例首次重症心脏瓣膜病置换术者随机分为乌司他汀组(A组),乌司他汀和抑肽酶组(B组),对照组(C组),各20例。
补充资料：倍他司汀
分子式：
CAS号：
性质：又名抗眩啶，甲胺乙吡啶，倍他(组)啶，贝他类组胺，陪它胳，陪他啶。本品为液体，沸点113～114℃(5kPa)。溶于水、乙醇、氯仿和乙酰，其二盐酸盐为白色结晶，熔点148～149℃，溶于水、乙醇和甲醇，不溶于苯、乙醚、氯仿和四氯化碳。为一种组胺类药物，具有扩张毛细血管的作用，适用于美尼尔氏综合征，血管性头痛及脑动脉硬化，并可用于治疗急性缺血性脑血管疾病，如脑血栓、脑栓塞、一过性脑供血不足等。制剂为片剂及注射剂。其副作用偶有口干、胃部不适、心悸、皮肤瘙痒等，个别病例偶有恶心、头晕、头胀、出汗等，一般不影响继续服药。消化性溃疡、支气管哮喘、褐色细胞瘤及孕妇慎用，儿童忌用，勿与组织胺类药物配用。
CAS号：
性质：又名抗眩啶，甲胺乙吡啶，倍他(组)啶，贝他类组胺，陪它胳，陪他啶。本品为液体，沸点113～114℃(5kPa)。溶于水、乙醇、氯仿和乙酰，其二盐酸盐为白色结晶，熔点148～149℃，溶于水、乙醇和甲醇，不溶于苯、乙醚、氯仿和四氯化碳。为一种组胺类药物，具有扩张毛细血管的作用，适用于美尼尔氏综合征，血管性头痛及脑动脉硬化，并可用于治疗急性缺血性脑血管疾病，如脑血栓、脑栓塞、一过性脑供血不足等。制剂为片剂及注射剂。其副作用偶有口干、胃部不适、心悸、皮肤瘙痒等，个别病例偶有恶心、头晕、头胀、出汗等，一般不影响继续服药。消化性溃疡、支气管哮喘、褐色细胞瘤及孕妇慎用，儿童忌用，勿与组织胺类药物配用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条